hydralazine and 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol

hydralazine has been researched along with 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siemann, DW1

Other Studies

1 other study(ies) available for hydralazine and 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol

ArticleYear
Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
    British journal of cancer, 1990, Volume: 62, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Hypoxia; Cyclophosphamide; Drug Synergism; Female; Hydralazine; Lomustine; Melphalan; Mice; Mice, Inbred C3H; Misonidazole; Sarcoma, Experimental; Stem Cells

1990